Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Sunday, March 7, 2021 · 536,493,395 Articles · 3+ Million Readers

Cancer Vaccines Market to reach US $10,688.8 Million By 2028 - Global Insights on Key Trends, COVID-19 Impact Analysis, Growth Drivers, Expansion Plans and Future Outlook: Adroit Market Research

North America accounted for the largest share of the global cancer vaccines market in 2020. Moreover, Asia is likely to show lucrative growth during the forecast period.

/EIN News/ -- Dallas, Texas, Jan. 15, 2021 (GLOBE NEWSWIRE) -- The “Global Cancer Vaccines Market Size 2020, By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines) Technology (Dendritic Cells, Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Viral Vector & DNA Cancer Vaccines) Indication (Cervical Cancer, Prostate Cancer, Others) End User (Pediatric, Adult) Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) and Forecast 2021 to 2028” study provides an elaborative view of historic, present and forecasted market estimates.

Request a pdf sample at https://www.adroitmarketresearch.com/contacts/request-sample/1815

The global cancer vaccines market is projected to reach USD 10,688.8 Million By 2028, growing at a CAGR of 13.1%. Upsurge in number of cancer patients, growing elderly populace and growing government relief in advancing cancer vaccines are some of the factors driving the growth of the global cancer vaccines market.

Adroit Market Research report on global Cancer vaccines market gives a holistic view of the market from 2018 to 2028, which includes factors such as market drivers, restraints, opportunities and challenges. The market has been studied for historic years from 2018 to 2019, with the base year of estimation as 2020 and forecast from 2021 to 2028. The report covers the current status and future traits of the market at global as well as country level. In addition, the study also assesses the key players based on their product portfolio, geographic footprint, strategic initiatives and overall revenue. Prominent players operating in the global cancer vaccines market have been studied in detail.

Browse the full report Table of Contents and List of Figures at https://www.adroitmarketresearch.com/industry-reports/cancer-vaccines-market

The global cancer vaccines market is categorized based on type, technology, indication and end user. On the basis of type, the market is segmented into preventive cancer vaccines and therapeutic cancer vaccines. The preventive cancer vaccines dominated the market in 2020. On the basis of technology, the market is segmented into dendritic cells (DC) cancer vaccines, recombinant cancer vaccines, antigen/adjuvant cancer vaccines, and viral vector & DNA cancer vaccines. The recombinant cancer vaccines dominated the market in 2020. On the basis of indication, the market is segmented into cervical cancer, prostate cancer, and others. On the basis of end user, the market is segmented into pediatric and adult.

North America dominated the market for cancer vaccines in 2020, while Asia Pacific set to grow at a highest CAGR as it offers lucrative opportunities for foremost companies. Key players of the global cancer vaccines market include Advaxis Inc., Dynavax Technologies Corporation, Amgen Inc., Generex Biotechnology Corporation, Immunocellular Therapeutics, Ltd, GlaxoSmithKline plc., Merck & Co., Inc., UbiVac, Sanpower Group Co. Ltd., Vaccinogen, Inc. among others.

Direct purchase the report at https://www.adroitmarketresearch.com/researchreport/purchase/1815

Major Points from Table of Contents:
1.    Introduction
2.    Research Methodology
3.    Executive Summary
4.    Market Outlook
5.    Cancer vaccines Market by Type, 2018-2028 (USD Million)
6.    Cancer vaccines Market by Indication, 2018-2028 (USD Million)
7.    Cancer vaccines Market by Technology, 2018-2028 (USD Million)
8.    Cancer vaccines Market by End-use, 2018-2028 (USD Million)
9.    Cancer vaccines Market by Region, 2018-2028 (USD Million)
10.    Competitive Landscape
11.    Company Profiles

Access research repository of Upcoming Reports @ https://adroitmarketresearch.com/upcoming.html  

About Us:
Adroit Market Research is a global business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.

Contact Us:
Ryan Johnson
Account Manager - Global
3131 McKinney Ave Ste 600
Dallas, TX 75204
Email ID: sales@adroitmarketresearch.com
Phone No.: +1 972-362 -8199
Connect with us: Facebook | Twitter | LinkedIn


Primary Logo

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release